Cost-effectiveness of genotyping to guide treatment

Pharmacogenomics. 2014 Apr;15(6):727-9. doi: 10.2217/pgs.14.24.
No abstract available

Keywords: clinical translation; clinical utility; cost–effectiveness; evidence; pharmacogenetics; pharmacogenomics; prioritization; xxx.

Publication types

  • Editorial

MeSH terms

  • Cost-Benefit Analysis / economics*
  • Delivery of Health Care / economics
  • Drug Therapy / economics*
  • Genotype
  • Humans
  • Pharmacogenetics / economics*